Bilgasem SM. Type 2 diabetic patients and Hba1c as a potential biomarker for dyslipidemia occurrence. alostah [Internet]. 2023Dec.2 [cited 2026Aug.19];(25). Available from: https://www.uotpa.org.ly/alostath/index.php/alostath/article/view/326